Form 8-K Edwards Lifesciences For: Apr 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Edwards Lifesciences (EW) PT Raised to $125 at Jefferies
April 27, 2016 8:19 AM EDTJefferies analyst Raj Denhoy reiterated a Buy rating and raised his price target on Edwards Lifesciences (NYSE: EW) to $125.00 (from $105.00) following strong results and outlook.
Denhoy commented, "EW delivered another exceptionally strong quarter. US TAVR sales were up a remarkable 64%and this was before the... More
